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Abstract
Background:  Measuring  arterial  stiffness  using  pulse
wave velocity (PWv) has become an important tool to
assess vascular function and cardiovascular mortality.
For subject with hypertension, end-stage renal disease
and diabetes, PWv has been shown to predict cardio-
vascular and all-cause mortality. We hypothesize that
PWv  would  also  predict  mortality  in  subjects  who
have undergone kidney transplantation.
Methods: a cohort of 330 patients with renal trans-
plantation was studied with a mean age at entry 51.4 ﾱ
0.75 years. Mean follow-up was 3.8 years (ﾱ 0.7 years);
16 deaths occurred during follow-up. at entry, togeth-
er with standard clinical and biochemical parameters,
PWv  was  determined  from  pressure  tracing  over
carotid and femoral arteries.
Results: With increasing PWv, there was a significant
increase in age, systolic blood pressure and pulse pres-
sure. In addition, subjects with higher PWv also ex-
hibited  more  frequently  the  presence  of  coronary
heart disease. on the basis of cox analyses, PWv and
systolic blood pressure emerged as predictors of all-
cause mortality. 
Conclusion: these results provide evidence that PWv
is a strong predictor of all-cause mortality in the pop-
ulation of renal transplant recipients.
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IntRoductIon
Measuring arterial stiffness has become a major tool
for assessing arterial function and cardiovascular mor-
tality [1]. In particular, pulse wave velocity (PWv) has
been proposed to be a clinically useful stiffness marker
due to its non-invasiveness and ease of use [2]. PWv
not only reflects the overall atherosclerotic burden of
the arterial tree but has also been shown to predict
cardiovascular  mortality  in  hypertension  [3,  4],  end-
stage renal disease [5, 6], and diabetes mellitus [6, 7].
another  population  with  high  cardiovascular  risk
includes subjects who have undergone kidney trans-
plantation. to date, only few studies have investigated
arterial  function  in  kidney  transplant  recipients,  and
little is known about the predictive value of PWv in
this population. therefore, we hypothesize that PWv
may also predict mortality in this group of patients. In
the present study, we evaluated the predictive value of
PWv in 330 kidney transplant patients. 
MatERIal, MEtHods and statIstIcs
study PoPulatIon
In this longitudinal study, 330 subjects with stable re-
nal  transplantation  were  recruited  from  our  renal
transplant  outpatient  clinic  [8].  Height  and  weight
were measured, and body mass index (BMI) was calcu-
lated as weight to height squared. laboratory measure-
ments were measured with commercially available kits
in our central laboratory. the study was performed in
accordance with the principles laid down in the decla-
ration of Helsinki.
HEModynaMIc MEasuREMEnts
Measurements were performed in a quiet, temperature-
controlled room after 10 minutes, in a supine position
according to the recommendations for user procedures
of clinical applications of arterial stiffness, task force
III [9], using the sphygmocor device (atcor Medical,
sydney, australia). Blood pressure and heart rate (mean
of three readings) were measured with an automatic
upper-arm oscillometric device (omron 705IT, om-
ron Medizintechnik, Mannheim, Germany). Pulse pres-
sure (PP) was calculated by subtracting diastolic (dBP)
from systolic blood pressure (sBP).
aortic  pulse  wave  velocity  (PWv)  was  calculated
from sequentially recorded pressure waveforms of the
carotid and femoral artery as reported previously by
our group [10, 11]. With a simultaneous EcG record-
ing of the R-wave as reference, the integral software
calculated  the  pulse  wave  transit  time.  anatomical
measurements of the distance between the carotid and
femoral artery were made on the surface of the body.
the distance between carotid artery recording site and
the suprasternal notch was subtracted from the dis-
tance from the suprasternal notch over the umbilicus
to the femoral artery recording site [12]. PWv [m x s-1]
was calculated as ratio between the distance travelled
by the pulse wave and pulse transmission time.
statIstIcal analysIs
the  outcome  events  studied  was  all-cause  mortality.
survival curves were estimated by the Kaplan-Meier
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were identified by use of logistic regression analysis
and the cox proportional hazards regression model.
the cohort was divided into 3 groups according to the
PWv < 7.5 m/s in the lower third, between 7.5 and
10.0 in the second third, and >10.0 in the upper third.
variables were considered to be prognostic when they
were found to be statistically significant (P<0.05) in
the logistic regression or the cox proportional hazards
regression models of all-cause mortality. 
P  <0.05  was  considered  statistically  significant.
data are expressed as mean ﾱ sd. statistical analysis
was  performed  using  GraphPad  Prism  4.0  for  Ms
Windows (GraphPad software, Inc., san diego, ca,
u.s.a.).
REsults
the characteristics of the cohort population in total
and  according  to  tertiles  of  PWv  are  displayed  in
table 1. With increasing PWv, there was a significant
increase in age, systolic blood pressure and pulse pres-
sure. In addition, subjects with higher PWv also ex-
hibited  more  frequently  the  presence  of  coronary
heart disease (table 1).
Mean follow-up was 3.87 years (ﾱ 0.7 years); during
this period, 16 deaths were recorded. according to the
cox analysis, the significant covariates retained by the
model were PWv and sBP (table 2). Figure 1 shows
the probabilities of all-cause survival as a function of
PWv  values.  comparisons  between  survival  curves
were highly significant with better survival for those
with lower PWv.
dIscussIon
In the present study, we showed for the first time that
PWv predicts all-cause mortaliy in renal transplant pa-
tients. We focused our analysis on all-cause mortality
since only 16 deaths occurred during the mean follow-
up time of 3.8 years. after renal transplantation, car-
diovascular complications remain common, but a large
number of patients also dies from infectious and tu-
moural  diseases  [13].  therefore,  it  was  unclear,
whether PWv would predict mortality in this popula-
tion. In the present study we could show that PWv
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Table 1. characteristics [mean ﾱ sEM] of the study population at inclusion according to tertiles of PWv. cHd, coronary heart
disease; aod, arterial occlusive disease.
Parameter total PWv < 7.5 PWv > 7.5 < 10 PWv > 10 P, anova
(n = 330) (n = 138) (n = 99) (n = 93)
age [years] 51.4 ﾱ 0.75 44.4 ﾱ 12.9 51.6 ﾱ 10.8 61.6 ﾱ 10.7 < 0.0001
Gender (male/female) 168/162 65/73 49/50 54/39 0.250
Body mass index [kg/m2 ] 25.3 ﾱ 4.3 25.0 ﾱ 4.5 25.8 ﾱ 4.5 25.2 ﾱ 3.6 0.366
Hypertension n = 298 n = 120 n = 98 n = 91 0.076
History of cHd n = 79 n = 18 n = 26 n = 35 < 0.0001
History of aod n = 26 n = 5 n = 10 n = 11 0.082
cholesterol [mg/dl] 213 ﾱ 41 208 ﾱ 46 218 ﾱ 38 215 ﾱ 36 0.247
triglycerides [mg/dl] 187 ﾱ 113 184 ﾱ 109 194 ﾱ 117 184 ﾱ 115 0.262
Glucose [mg/dl] 108 ﾱ 32 102 ﾱ 31 108 ﾱ 29 118 ﾱ 36 0.0006
systolic blood pressure [mmHg] 149 ﾱ 20 142 ﾱ 20 152 ﾱ 20 157 ﾱ 19 < 0.0001
diastolic blood pressure [mmHg] 83 ﾱ 11 83 ﾱ 11 83 ﾱ 9 81 ﾱ 18 0.372
Pulse pressure [mmHg] 67 ﾱ 18 59 ﾱ 15 69 ﾱ 17 76 ﾱ 18 < 0.0001
Heart rate [b.p.m.] 67 ﾱ 13 66 ﾱ 12 68 ﾱ 12 67 ﾱ 15 0.473
Pulse wave velocity [m/s] 9.1 ﾱ 3.3 6.2 ﾱ 0.8 8.5 ﾱ 0.8 13.1 ﾱ 2.9 < 0.0001
Table  2.  Proportional Hazards Regression analysis of all-
cause Mortality. sBP, systolic blood pressure; cHd, coro-
nary heart disease.
Parameter Regression  sE z value P
coefficient
PWv 0.066 0.024 2.704 0.0055
age -0.006 0.006 -1.038 0.3083
sBP -0.007 0.003 -2.048 0.0406
Glucose -0.001 0.002 -0.273 0.7846
cHd 0.138 0.152 0.912 0.3620
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Fig. 1. Probabilities of overall survival in study population ac-
cording to level of PWv divided into tertiles. comparisons be-
tween survival curves were statistically significant (P = 0.047).
5) Nürnberger##_Umbruchvorlage  15.10.10  19:00  Seite 453predicts  mortality  in  renal  transplant  patients  even
during a relatively short follow-up period of 3.8 years.
these  results  are  consistent  with  previous  reports
showing the strong predictive value of PWv in popu-
lations of hypertensives [3, 4], patients with end-stage
renal disease [5, 6], and diabetes mellitus [6, 7].
Hemodynamically, stiffening of the aortic tree re-
sults in characteristic changes of the blood pressure
pattern [2]. aortic stiffening leads to a rise of systolic
and  a  fall  of  diastolic  blood  pressure  resulting  in  a
widening of the pulse pressure. Results from our study
are consistent with such hemodynamic concept in that
subjects with higher PWv also exhibited higher sys-
tolic blood pressure and pulse pressures as a conse-
quence of arterial stiffening. 
several  other  studies  have  investigated  stiffness
markers in renal transplant patients. Bahous et al. fol-
lowed up 106 transplant subjects, and found that to-
bacco consumption and acute renal rejection influence
aortic stiffness as measured by PWv [14]. two other
studies have investigated the effect of renal transplan-
tation on arterial stiffness, and demonstrated that renal
transplantation improved PWv and augmentation in-
dex in subjects who underwent renal transplantation
[15, 16]. Recently, schwenger et al. showed in a cohort
of 76 kidney allograft patients that PWv, pulse pres-
sure, and intima-media-thickness are independent de-
terminants of the resistance index, a strong predictor
of kidney allograft survival [17]. our data on 330 renal
transplant  recipients  extend  these  associations  be-
tween stiffness markers, cardiovascular risk factors and
renal  disease  to  the  predictive  value  of  stiffness
markes in this patient population. 
In  addition  to  PWv  also  systolic  blood  pressure
predicted mortality. Hypertension in renal transplant
recipients can originate from different sources includ-
ing marginal renal function, use of immune suppres-
sive drugs, and renal artery stenosis. despite the inho-
mogeneous  pathogenesis  of  arterial  hypertension  in
renal  transplant  patients,  this  classical  cardiovascular
risk  factor  predicts  mortality  in  renal  transplant  pa-
tients. 
clInIcal IMPlIcatIon
the results of the present study show that the classical
marker of arterial stiffness PWv predicts mortality in
renal transplantation. stiffness markers are increasing-
ly used in population studies to evaluate cardiovascular
morbidity and mortality. our data suggest, that also in
renal transplant subjects stiffness markers may be used
as tools for the prediction of all-cause mortality. Even
though it is very likely, further studies are required to
evaluate the predictive value of PWv for cardiovascu-
lar mortality.
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